Research is focusing on therapeutic approaches for chronic lymphocytic leukemia (CLL), including targeted therapy and combination treatments. Various studies are exploring the mechanisms of immune evasion in cancer and potential treatments, such as ibrutinib and triplet therapy. The outcomes and side effects of these treatments are also being examined, with some studies highlighting concerns like hypertension and cardiovascular toxicity.